Category Archives: Investment

Shervin Pishevar’s prediction of the future

Shervin Pishevar is a peculiar investor. He does not just sit around watching numbers all day. He is interested in matters affecting the country’s economy and the world’s at large. In general, he is a chatty investor. In 2008 for instance, he realized that Facebook would soon have an identity crisis. Instead of quietly watching as the situation unfolded. He published an article. True to his word, Facebook did face an identity crisis.

This year, Shervin Pishevar foresees a grim future for the US economy. The investor who had kept a low profile since December posted 50 messages on twitter explaining why he thought the US economy will experience a 6000 point decline. Here are some of the predictions he made:

Bonds are volatile

The government has always used bonds to correct the market. Though useful in easing market strains, it will not be useful anymore because the government has used it too often and every tool has its limits.

Silicon Valley has gone global

Silicon Valley was once the hub of tech inventions. Today, Silicon Valley is not a place, it is an idea gone global. Everyone across the globe is great ideas and inventions. While this is not a bad thing for the global economy, Shervin Pishevar argues that it is not good for the country’s economy. Since the US has lost exclusivity on ideas and talent, the economy can no longer bank on these as a stronghold.

US will lose to countries that capitalize on speed in execution

Recently, as a demonstration that they have speed of execution, China built a railway station in 9 hours. On the other hand, The US government and companies are stuck in short term thinking. This has resulted in the decay of infrastructure.

Big companies will continue to hold on to too much power

Silicon valley’s big five: Alphabet, Amazon, Apple, Facebook, Microsoft hold on to too much power. As a result, they are stifling start-ups. For years, the trend has been acquisition. Big companies simply buy out their competitions.

Other than the grim forecasts, Shervin Pishevar also foresees the birth of a new type of economy. His tweets seem to suggest that impending economic disaster will make was for a new borderless and classless economy.

http://nymag.com/selectall/2016/10/the-kink-in-elon-musks-hyperloop.html

Sahm Adrangi Is Investigating Proteostasis’ Breakthrough Claims

Sahm Adrangi is a well-known investor and business executive in the United States who regularly calls out companies that he believes should be avoided or are making false claims. The latest company under attack by Sahm Adrangi is Proteostasis, a biotech company that has been working on a new drug to combat cystic fibrosis for patients. While this sounds like a good thing, there are a lot of concerns surrounding this “breakthrough” drug that they have been developing. Sahm Adrangi did some digging into the company and various analysts at Kerrisdale Capital have found some concerning data as well. Proteostasis actually has very messy data to sort through, which is not a good thing to see when a company making such strong claims.

In Proteostasis’s test period for their drug, CFTR amplifier PTI-428, only four patients were used for their control. Which means results are most likely skewed as the testing sample is much too small. Proteostasis claimed an increase of roughly 5 percent for patient lung performance, which is most likely just placebo according to Kerrisdale. Over the years, Sahm Adrangi has had no qualms facing biotech companies and their claims, including some of the biggest in the industry.

The data provided by Proteostasis is incomplete as well, which indicates poor testing methods and lack of organizations. Another concerning part of these claims being made by Proteostasis is that there is a lot of pressure on them to create a successful product. Should Proteostasis’s new drug prove ineffective, they stand to lose upwards of 90 percent of their company share value, which would basically mean bankruptcy for Proteostasis. Until this biotech company does a larger study that is complete and provides accurate data, Sahm Adrangi is going to take the short position at Kerrisdale Capital and urges his fellow investors to do the same. As long as Proteostasis continues to show transparency in their procedure and data, Sahm Adrangi will push Kerrisdale’s negative report to the public.

http://fortune.com/2016/04/21/sahm-adrangi-kerrisdale-short-sale/

Eric Lefkofsky: Tempus Progression Against Cancer

It was recently reported that Eric Lefkofsky, CEO of Tempus, has been developing breakthroughs in precision, data-enabled medicine. With approximately 40% of US adults diagnosed with cancer sometime in their lifetime and the cancer diagnosis is expecting to approach over 19 million people by the year 2024, amazing groundbreaking companies, like Tempus, are creating better-looking prognosis.

Tempus has a goal to transform the delivery process of cancer care. They have developed a way to effectively analyze the molecular and clinical data of patients. Tempus had the means for analytics software development, but obtaining affordable medical and clinical data was an issue at first. Tempus also had to overcome the collecting and storing information process concerning cancer patients. This information was mainly in the form of doctor’s notes known as progress notes; however, these notes weren’t able to be captured and analyzed in software. Nevertheless, Tempus created software with the capability to process natural language and optical character recognition. And now the advances in technology and science made it possible for the cost of the genome to cost approximately $5,000, and it is expected to plunge to a lower price tag. Obtaining the genome used to be very expensive up to $100 million. Human genome sequencing gives clues that are beneficial against cancer, and Tempus is promoting it.

About Eric Lefkofsky

Erick Lefkofsky is the CEO and co-founder of Tempus. He is also the chairman and co-founder of Groupon, a worldwide e-commerce marketplace, and he is the founding partner of Lightbank, a venture capital fund for disruptive technologies, to name a few.

He was born in September 1969, and he is originally from Southfield, Michigan. In 1991, he graduated with high honors from the University of Michigan in Ann Arbor. In 1993, he graduated from the University of Michigan Law School earning his Juris Doctor degree. In addition to becoming a major player in the dot-com revolution, Lefkofsky held teaching positions at the Northwestern University’s Kellogg School of Management and DePaul University’s Kellstadt Graduate School of Business. Also, he is an adjunct professor at the University of Chicago’s Booth School of Business.

All About Agora Financial

Agora Financial is one of the most exciting businesses in the Baltimore, Maryland area. This firm’s publications give Americans the tools they need to succeed. It’s staffed by some of the highest-profile people in fields like law, finance, technology and defense. Reading their insights gives subscribers the ultimate in insider information.

The world of high finance can be confusing for the uninitiated. Agora Financial’s team of experts breaks everything down so that laypeople can understand what’s really going on in the world. The expert reporting and analysis makes it possible for subscribers to protect and expand their assets.

The writers and editors at Agora newsletters are well-placed to get information earlier than other outlets. In fact, the Wall Street Journal, CNBC and Fox Business News often report on this publisher’s finds and analysis. Famed negotiator Jim Rickards is one of Agora’s most popular authors.

The Agora Financial stable of newsletters includes Kinetic Profits, the Dollar Trade Club and The Takeover Alert. Whether your goals are short-term or long-term, there’s a publication that will help you achieve them. A recent addition, The Crypto Report, has taken off in recent weeks as Bitcoin has dominated the news.

Agora Financial is also unique in that it’s totally independent. In a world of pay-for-play “sponsored” content, this family of publications never trades cash for coverage. That means you can always trust their reporting. It’s also another reason why their analysis seems so clear-cut, compared to the competition.

This firm creates videos and online seminars in addition to print content. Agora Financial has a big presence on social media, especially Twitter. Agora has streams of both free and premium content.

Agora Youtube channel: Youtube.com/channel/UC_PFk4NAr18UClM_wxZuyOg

Sahm Adrangi Mobilizes Investors to Raise $100 Million Raising Kerrisdale`s Investment Fund

Kerrisdale Capital Management, through Sahm Adrangi, mobilized investors to raise around $ 100 million for a single stock. Kerrisdale`s co-investment is a unique fund and first of its kind. Most Hedge fund managers raise capital to focus on specific projects such as the recovery of failing energy companies or mortgage-backed residentials.

Kerrisdale is a relatively small firm as compared to the Hedge fund organizations. The firm plans to use the investment fund to purchase short stock and unveil an unnamed firm as a public company. In an email reviewed by Reuters, Adrangi thanked the investors for their commitment. Sahm noted that Kerrisdale had raised the required amount of capital within a short time.

Adrangi noted that the organization endeavored to help every investor understand the mission of the $10 billion organization. Sahm had some progressive insights that would help the company grow. Adrangi is working with the organization`s analyst, Shane Wilson, to prepare a website, videos and a report that would convince others about Kerrisdale`s thesis. The two will present their collective research in the upcoming campaign.

A speaker, on the anonymity condition, revealed that the target company will be revealed in mid-May because the information was private. The public will learn about the organization objective during the unveiling. The investment fund is being used to purchase stock to establish Kerrisdale`s position in unnamed organization.

Kerrisdale now manages over & 500 million after the investment fund. The firm has a history of betting against organizations before taking its case public. Kerrisdale has been involved in activist positions at Globalstar and Sage Therapeutics. The organization has recorded an average of 28% profit, from its betting, for the last five years.

About Adrangi

Apart from being the founder of Kerrisdale Capital Management, Adrangi is the Chief Investment Officer of the company. Since its establishment in 2009, Sahm has played a significant role in all of the firm`s development. He started the organization with less than $ 1 million. For more info about us: https://www.linkedin.com/in/sahm-adrangi-3548541 click here.

Adrangi is a holder of a Bachelor`s Degree in Economics from Yale University. He started his career at Deutsche Bank where he served as a credit officer. He worked as a credit advisor at Chanin Capital Partners. Before he established Kerrisdale, Sahm worked at Longacre Management.